{"name":"Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.","slug":"shanghai-pharmaceutical-group-biological-therapy-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd. is a biotechnology company focused on developing innovative therapies in the field of biological treatments. The company has one drug, B019, currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"B019","genericName":"B019","slug":"b019","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"B019","genericName":"B019","slug":"b019","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWE13UWg0d1UtcXpDY1BhTEwtNFUzU0pxWC1PcDgySUsxblBXai1aSkdrNmphaUtEQVRrVi04VzBGMUwwaG9YYVFiUGpoR0JFWTNaYldhWENyX3ZWRHJDSC1jdU5uM2FfN2Y3YkpHTVQ5VzVub2I1QUI3X3Frd3k3MndoU3k4eFIyNG5hT2JGNElYV1pMRzFyeU1kZmlhYlp0RG1IYmlIQkdmQmY4bjZ4UHkzaklVVTVETVVuZHlhQXJlUGRPWFVGeFRSa1dDVHdiOXV3cWJVenlUQWZpN3VFbk1RVXZPbFRzelNVZg?oc=5","date":"2026-04-02","type":"pipeline","source":"Barchart.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQWHhabDZXemlwYzdkOXNKRk1FUC1KUUZ2VHd2VWIzSkxBaEhRbGJhTVE1V041cGl0RHRRSU5BT2FuelM2UkhsdUpTb1NkTHhNcUx2eGF2SXlNUlhob1NGN2lNeU1RcUNOR2w5SmVqM1hacG9tcUtabEFKTEE4dWpjdjMzZm9wSWFUbWdoaTVPS21LR280T0NHUWhaQ2ZnaTkzZkJNWV9JVVJpZm9pLWN3NHVWQmxQNXV6ZFVyUEhYaW9RZG9Sa0F3LWdteXpXaEFhQUV1MXB0dFRJS1RHcmc?oc=5","date":"2026-03-12","type":"trial","source":"The Globe and Mail","summary":"Shanghai Bao Pharma Wins NMPA Nod for New KJ101 Gastroscopy Trial - The Globe and Mail","headline":"Shanghai Bao Pharma Wins NMPA Nod for New KJ101 Gastroscopy Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPN0FacjVYenlNdlVXN2VkT1AwS2JteDNHRWlkLUFiQkkxWUx0dnpVejBLbWtseHNDa09OSHl1TnNZZDQwVjRtVGhMelpPdVYzS0N0WDluLVV4RFpNV19rTWJXbUJCLVNraTZSeElIOG1YcFV6amdXMXoxemhtSnQxSk1oUndvY3N0T1ZPdzV6MGV3WG5Bb3Fna1VMQ3JqQQ?oc=5","date":"2026-02-24","type":"deal","source":"Pharmaceutical Technology","summary":"GSK backs siRNA modality through $1bn Frontier deal - Pharmaceutical Technology","headline":"GSK backs siRNA modality through $1bn Frontier deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPRmtYZ3FyQmJ6WGplejNCTUJ2Q1ktcnc4Sk1TRk5WWGp0STBxUDY0ZFIzMGt6ajJPUmNVcUNkQW9sYmtDb05FZ3FycXhqQXNFVGF1VDJmWHlUa1NkeDZBSVNxaXQ3ZDRpMDVEZVJ5dzV2aFFuNW1HMHFLNjZxR3c4UTZDUQ?oc=5","date":"2026-01-26","type":"deal","source":"Insilico Medicine","summary":"Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies - Insilico Medicine","headline":"Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Car","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxNdFUtblN4eXF6Mk5KcUdZdXNIZDA1WlFRWlhlNzMtcC1ON1NCc2huOFMyZjA2SjdJNWRrdERjY1oyclNIUUhvdW5OZld5Y2E3UFJ2Y3FHaGRIWDJWUUh3QmFPVjlNOXFWZC1rZTlMdENVTlRjQ2FROExYUGRINlBCazUtbC10OThtanVqejU2bHhybDdiNFJKeEgtcGRHSG5lTG4tMkhPMWpEYVVGYmlBQjFfdDJNUXVKRkRnMnJXVTBnZWdQLWhzdlVhclZEX3hTSzF2VTJBRHJFUkdHQW5yT1hBUnVJSnpieU1xLUVmMDhxdEQ5ak5yOEhzcFdnN0h5c0ZoSmstNEVTRElOWEY3YzZGdnlLUk9IbWZxQzVFM3oxdkhaVXUxdFEzUV9GYWh4TkxHQ0N5eTk2QjhIdk1PSGtqSkdYbFhwQV9OYjN3NTN3X2NYS3hlRGItU0s?oc=5","date":"2025-12-16","type":"deal","source":"BioSpace","summary":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Biosci","headline":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOZFFXbjY5X19SVW9xSlRDdjdlUkgzYnRNbnFFRzU5WjBwUXpyS2xYRm5Sd2sxWndTZ3RpOHFiNEJjbU1CXzg1M3hwSkN5TW1tY05TZG5BMmtGNmZNS1F5WGRxR3F5MzhqSnRzWndvaS0zMGgxQWdfU2VwU1V2ckZxYVVEOGxDRlMzTEVsZm5yU045QWhLWURlTXdRcFhXSXZTb0h0WjVBMklWTTNLVG5hdm04MG1hWUJXUEdUSFlnZHNPT2VuNlFkNXEtVGNXc1FPang4Q09JOVVKMjNTYjB2ZHd3QlVlUC13ZkR2RG5OV0llZ3hicUg5SjdPc1lieXE4eUR0X2lnRTY0SUlDTzRPV1dpQU1tMWRDYjZGTGh1enZpS1RJa2w1SWRtbWF4dw?oc=5","date":"2025-06-26","type":"trial","source":"GlobeNewswire","summary":"Autism Spectrum Disorder Clinical Trial Analysis: Key - GlobeNewswire","headline":"Autism Spectrum Disorder Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE43eVR1blVmTDV0UVNJbFd5TnVkZ1BVY3hPdEFveFJMVzNOUUJpU2NES1pzNUNZYkNuRldMbkF4VWdBSE9qZkltTDZka0JTZ0xEQnNQakxUa1FfUmJP?oc=5","date":"2024-07-05","type":"pipeline","source":"EurekAlert!","summary":"Insilico delivers second preclinical candidate compound (PCC) to Fosun Pharma - EurekAlert!","headline":"Insilico delivers second preclinical candidate compound (PCC) to Fosun Pharma - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQQzJib21JOGxqU0VzMlcyZWhyWWFJYXZ6d2JBZ1ZDUE1IOXJDLVhiUy1CRElGcTRLNFZHb3hoRDlXR2w4UXA5RGZZRjVVMkx4ak5YLXgybzFqbWM2ZVp6aVVLYXdtUk9kejVaSlJGOWRyXzJaYjlmYVJpMU91SGFoWHBnVXBUaVlFUXgxSFV3S3prWndWWXFfdXRZeTZLZ3VZMEY2U3dGT0lrV1VEN0t3dUFaMm5La3lISGJmbkZnOGswVl90MC1jWmlXbFY5aXI5T05JTW1yMUprVkNn?oc=5","date":"2023-05-10","type":"pipeline","source":"PR Newswire","summary":"Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements - PR Newswire","headline":"Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1WWDEzUDhjelM3RzBvdUNoOTdtLWdMYjRSNGFmblpGVzFScjNQMlUxYlF1ZDRNRGR1ckM3bXBiak55OHV4bjdfUUVmdGZ0TmlKSEZIVG5Fd3p2RE9RaWdn?oc=5","date":"2022-01-04","type":"pipeline","source":"Nature","summary":"Leading innovative drug discovery and development - Nature","headline":"Leading innovative drug discovery and development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPS0pYR1QwbFFCWHdPVHN1ZjI1Vzd0UzVwMVl4TEZscU4yN0hUY3NhS1dYVGQyd0c5YS1hQ0p1V0duc0dHZWE2Nm5WTUxmaVo0ZnFSMnFIX1BZX1VxV19EanhaN2F4RXlVdmZSbUR5NFM0Zkx0TjB3TWtMZnpMVWNHX21ZN1NpN0tLcEZWNEFGWEQ5YjNSbXc4MWlUa08wMDRZNW1KeVdFU0JGRDkzYmkyNVV3NV91MllTWnFfYi1WUGhVdEszZHI3ZHo2N1hqVFRrLUFHVQ?oc=5","date":"2021-07-02","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Shanghai Pharma and Russia’s Biocad form joint venture to sell cancer and autoimmune drugs in China - Generics and Biosimilars Initiative","headline":"Shanghai Pharma and Russia’s Biocad form joint venture to sell cancer and autoimmune drugs in China","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}